SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories - Quaterly Results

31 Jan 2022 Evaluate
The company witnessed a 15.88% growth in the revenue at Rs. 860.20 millions for the quarter ended December 2021 as compared to Rs. 742.34 millions during the year-ago period.Net Profit witnessed a 187.66% growth almost the double from Rs. 15.24 millions to Rs. 43.84  millions  of same quarter last year.OP of the company witnessed a marginal growth to 113.61 millions from 81.75 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 860.20 742.34 15.88 2253.86 2304.55 -2.20 3036.29 2743.20 10.68
Other Income 7.21 7.88 -8.50 28.59 16.00 78.69 24.49 46.56 -47.40
PBIDT 113.61 81.75 38.97 271.12 298.84 -9.28 392.62 244.38 60.66
Interest 17.50 23.43 -25.31 68.75 79.54 -13.57 108.86 126.55 -13.98
PBDT 96.11 58.32 64.80 202.37 167.50 20.82 231.95 117.83 96.85
Depreciation 35.31 36.23 -2.54 109.60 107.21 2.23 146.14 132.71 10.12
PBT 60.80 22.09 175.24 92.77 60.29 53.87 85.81 -14.88 -676.68
TAX 16.96 6.85 147.59 27.05 17.97 50.53 29.64 -32.28 -191.82
Deferred Tax 6.99 0.07 9885.71 12.23 -3.61 -438.78 29.47 -31.05 -194.91
PAT 43.84 15.24 187.66 65.72 42.32 55.29 56.17 17.40 222.82
Equity 162.42 162.42 0.00 162.42 162.42 0.00 162.42 161.81 0.38
PBIDTM(%) 13.21 11.01 19.93 12.03 12.97 -7.24 12.93 8.91 45.15

Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×